Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan M Fischer

Showing results (31-40 of 89) with videos related to

Pageof 9
Sort By:
The Prostate|January 25, 2005
Evidence for downregulation of calcium signaling proteins in advanced mouse adenocarcinomaViola C Ruddat, Stephanie Whitman, Russell D Klein, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 18, 2013
The chemopreventive efficacies of nonsteroidal anti-inflammatory drugs: the relationship of short-term biomarkers to long-term skin tumor outcomeCarol D Mikulec, Joyce E Rundhaug, Melissa S Simper, et al.
Oncogene|November 24, 2004
An antitumorigenic role for murine 8S-lipoxygenase in skin carcinogenesisEunjung Kim, Joyce E Rundhaug, Fernando Benavides, et al.
Oncology Reports|January 5, 2006
Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancerJason Gee, I-Ling Lee, David Jendiroba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppressionHui Xu, Satish Cheepala, Elisabeth McCauley, et al.
Molecular Carcinogenesis|July 9, 2011
The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumorsInok Surh, Joyce E Rundhaug, Amy Pavone, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2004
Suppression of 15-hydroxyprostaglandin dehydrogenase messenger RNA concentration, protein expression, and enzymatic activity during human ureteral obstructionTravis J Jerde, William S Mellon, Susan M Fischer, et al.
Molecular Carcinogenesis|January 24, 2007
Cyclooxygenase-2 deficiency increases epidermal apoptosis and impairs recovery following acute UVB exposureJacqueline K Akunda, Kyung-Soo Chun, Alisha R Sessoms, et al.
International Journal of Cancer|August 21, 2008
Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancersRonald A Lubet, Susan M Fischer, Vernon E Steele, et al.
Carcinogenesis|October 19, 2007
The resistance to the tumor suppressive effects of COX inhibitors and COX-2 gene disruption in TRAMP mice is associated with the loss of COX expression in prostate tissueXingya Wang, Jennifer K L Colby, Peiying Yang, et al.
Pageof 9

Showing results (31-40 of 89) with videos related to

Sort By:
Pageof 9
The Prostate|January 25, 2005
Evidence for downregulation of calcium signaling proteins in advanced mouse adenocarcinomaViola C Ruddat, Stephanie Whitman, Russell D Klein, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 18, 2013
The chemopreventive efficacies of nonsteroidal anti-inflammatory drugs: the relationship of short-term biomarkers to long-term skin tumor outcomeCarol D Mikulec, Joyce E Rundhaug, Melissa S Simper, et al.
Oncogene|November 24, 2004
An antitumorigenic role for murine 8S-lipoxygenase in skin carcinogenesisEunjung Kim, Joyce E Rundhaug, Fernando Benavides, et al.
Oncology Reports|January 5, 2006
Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancerJason Gee, I-Ling Lee, David Jendiroba, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2006
Chemoprevention of skin carcinogenesis by phenylretinamides: retinoid receptor-independent tumor suppressionHui Xu, Satish Cheepala, Elisabeth McCauley, et al.
Molecular Carcinogenesis|July 9, 2011
The EP1 receptor for prostaglandin E2 promotes the development and progression of malignant murine skin tumorsInok Surh, Joyce E Rundhaug, Amy Pavone, et al.
The Journal of Pharmacology and Experimental Therapeutics|January 14, 2004
Suppression of 15-hydroxyprostaglandin dehydrogenase messenger RNA concentration, protein expression, and enzymatic activity during human ureteral obstructionTravis J Jerde, William S Mellon, Susan M Fischer, et al.
Molecular Carcinogenesis|January 24, 2007
Cyclooxygenase-2 deficiency increases epidermal apoptosis and impairs recovery following acute UVB exposureJacqueline K Akunda, Kyung-Soo Chun, Alisha R Sessoms, et al.
International Journal of Cancer|August 21, 2008
Rosiglitazone, a PPAR gamma agonist: potent promoter of hydroxybutyl(butyl)nitrosamine-induced urinary bladder cancersRonald A Lubet, Susan M Fischer, Vernon E Steele, et al.
Carcinogenesis|October 19, 2007
The resistance to the tumor suppressive effects of COX inhibitors and COX-2 gene disruption in TRAMP mice is associated with the loss of COX expression in prostate tissueXingya Wang, Jennifer K L Colby, Peiying Yang, et al.
Pageof 9